Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
8
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
8
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
8
×
boston top stories
fda
startups
deals
novartis
biogen
cancer immunotherapy
clinical trials
crispr
eli lilly
takeda pharmaceutical
allergan
What
bio
roundup
life
science
companies
ipo
new
pharmaceutical
black
covid
diamond’s
drugs
gene
latest
medicines
millions
moves
sciences
therapeutics
typically
week
acquisitions
activity
alzheimer’s
announced
appetite
approvals
bails
becker
billions
biogen
biotechs
brand
bread
bridgebio
butter
buyout
cancer
capital
car
Language
unset
Current search:
ipo
×
cancer
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
